• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有亚膦酰二咪唑和双膦基胺配体的结构多样的金属配位化合物,作为血小板激活因子的潜在抑制剂。

Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.

机构信息

Biochemistry Laboratory, Faculty of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece.

出版信息

Bioinorg Chem Appl. 2010;2010. doi: 10.1155/2010/731202. Epub 2010 Jun 28.

DOI:10.1155/2010/731202
PMID:20689709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2905917/
Abstract

Metal complexes bearing dichalcogenated imidodiphosphinate R(2)P(E)NP(E)R(2)' ligands (E = O, S, Se, Te), which act as (E,E) chelates, exhibit a remarkable variety of three-dimensional structures. A series of such complexes, namely, square-planar [Cu{(OPPh(2))(OPPh(2))N-O, O}(2)], tetrahedral [Zn{(EPPh(2))(EPPh(2))N-E,E}(2)], E = O, S, and octahedral [Ga{(OPPh(2))(OPPh(2))N-O,O}(3)], were tested as potential inhibitors of either the platelet activating factor (PAF)- or thrombin-induced aggregation in both washed rabbit platelets and rabbit platelet rich plasma. For comparison, square-planar [Ni{(Ph(2)P)(2)N-S-CHMePh-P, P}X(2)], X = Cl, Br, the corresponding metal salts of all complexes and the (OPPh(2))(OPPh(2))NH ligand were also investigated. Ga(O,O)(3) showed the highest anti-PAF activity but did not inhibit the thrombin-related pathway, whereas Zn(S,S)(2), with also a significant PAF inhibitory effect, exhibited the highest thrombin-related inhibition. Zn(O,O)(2) and Cu(O,O)(2) inhibited moderately both PAF and thrombin, being more effective towards PAF. This work shows that the PAF-inhibitory action depends on the structure of the complexes studied, with the bulkier Ga(O,O)(3) being the most efficient and selective inhibitor.

摘要

含有二卤代亚膦酸酯 R(2)P(E)NP(E)R(2)'配体的金属配合物(E = O、S、Se、Te),作为(E,E)螯合物,表现出显著的三维结构多样性。一系列这样的配合物,即平面正方形 [Cu{(OPPh(2))(OPPh(2))N-O, O}(2)]、四面体形 [Zn{(EPPh(2))(EPPh(2))N-E, E}(2)]、E = O、S 和八面体形 [Ga{(OPPh(2))(OPPh(2))N-O,O}(3)],被测试为血小板激活因子(PAF)或凝血酶诱导的洗涤兔血小板和兔富含血小板血浆聚集的潜在抑制剂。为了比较,平面正方形 [Ni{(Ph(2)P)(2)N-S-CHMePh-P, P}X(2)]、X = Cl、Br、所有配合物的相应金属盐和(OPPh(2))(OPPh(2))NH 配体也进行了研究。Ga(O,O)(3)表现出最高的抗 PAF 活性,但不抑制凝血酶相关途径,而 Zn(S,S)(2),具有显著的 PAF 抑制作用,表现出最高的凝血酶相关抑制作用。Zn(O,O)(2)和 Cu(O,O)(2)适度抑制 PAF 和凝血酶,对 PAF 更有效。这项工作表明,PAF 抑制作用取决于所研究的配合物的结构,体积较大的 Ga(O,O)(3)是最有效和选择性的抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/fe71b80245f4/BCA2010-731202.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/7921a7a702e0/BCA2010-731202.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/3ff0012a9994/BCA2010-731202.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/da8b23115e38/BCA2010-731202.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/343d745811d3/BCA2010-731202.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/3e6548ab9eed/BCA2010-731202.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/8ed612c2fdac/BCA2010-731202.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/e0c1f7805162/BCA2010-731202.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/fe71b80245f4/BCA2010-731202.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/7921a7a702e0/BCA2010-731202.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/3ff0012a9994/BCA2010-731202.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/da8b23115e38/BCA2010-731202.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/343d745811d3/BCA2010-731202.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/3e6548ab9eed/BCA2010-731202.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/8ed612c2fdac/BCA2010-731202.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/e0c1f7805162/BCA2010-731202.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5197/2905917/fe71b80245f4/BCA2010-731202.008.jpg

相似文献

1
Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.具有亚膦酰二咪唑和双膦基胺配体的结构多样的金属配位化合物,作为血小板激活因子的潜在抑制剂。
Bioinorg Chem Appl. 2010;2010. doi: 10.1155/2010/731202. Epub 2010 Jun 28.
2
Conversion of tetrahedral to octahedral structures upon solvent coordination: studies on the M[(OPPh2)(SePPh2)N]2 (M = Co, Ni) and [Ni{(OPPh2)(EPPh2)N}2(dmf)2] (E = S, Se) complexes.在溶剂配位作用下四面体到八面体结构的转化:M[(OPPh2)(SePPh2)N]2(M = Co,Ni)和[Ni{(OPPh2)(EPPh2)N}2(dmf)2](E = S,Se)配合物的研究。
Dalton Trans. 2011 Jan 7;40(1):169-80. doi: 10.1039/c0dt00928h. Epub 2010 Nov 12.
3
First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.第一过渡金属配合物结合 2-(2'-吡啶基)喹喔啉配体(pqx)作为有效的炎症介质:对血小板激活因子(PAF)和凝血酶的细胞毒性性质和生物学活性。
Molecules. 2023 Oct 1;28(19):6899. doi: 10.3390/molecules28196899.
4
Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(-CR)Co{P(OEt)O}], (R = H, Me; Et = -CH) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.锡(II)和锡(IV)配合物,含有氧三角配位体 [(-CR)Co{P(OEt)O}],(R = H,Me;Et = -CH),作为有效的炎症介质抑制剂:对血小板激活因子(PAF)和凝血酶的细胞毒性性质和生物活性。
Molecules. 2023 Feb 16;28(4):1859. doi: 10.3390/molecules28041859.
5
In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.抗生素对血小板激活因子和凝血酶的体外抗炎和抗凝作用。
J Inflamm (Lond). 2011 Jul 7;8:17. doi: 10.1186/1476-9255-8-17.
6
Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.血小板活化因子和1-O-烷基-2-O-甲基-sn-甘油-3-磷酸胆碱在血小板和白血病细胞上的两种不同作用位点。
Biochem Cell Biol. 1992 Feb;70(2):129-35. doi: 10.1139/o92-019.
7
Synthesis, characterization, and ligand exchange reactivity of a series of first row divalent metal 3-hydroxyflavonolate complexes.一系列第一过渡金属二价 3-羟基黄酮酸盐配合物的合成、表征及配体交换反应性。
Inorg Chem. 2010 Jan 4;49(1):82-96. doi: 10.1021/ic901405h.
8
Spectroscopic study of molecular structures of novel Schiff base derived from o-phthaldehyde and 2-aminophenol and its coordination compounds together with their biological activity.由邻苯二甲醛和2-氨基苯酚衍生的新型席夫碱及其配位化合物的分子结构的光谱研究及其生物活性
Spectrochim Acta A Mol Biomol Spectrosc. 2009 Sep 1;73(5):833-40. doi: 10.1016/j.saa.2009.04.005. Epub 2009 Apr 22.
9
Structural diversity in supramolecular complexes of MCl(3) (M = As, Sb, Bi) with constrained thio- and seleno-ether ligands.MCl(3)(M = As、Sb、Bi)与受限硫代和硒代醚配体形成的超分子配合物的结构多样性。
Inorg Chem. 2010 Oct 4;49(19):9036-48. doi: 10.1021/ic101296e.
10
Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses.血小板活化因子刺激的兔血小板中的酪氨酸激酶活性。金雀异黄素抑制酪氨酸激酶对血小板信号分子升高和功能反应的影响。
Eur J Biochem. 1993 Sep 1;216(2):639-51. doi: 10.1111/j.1432-1033.1993.tb18184.x.

引用本文的文献

1
Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism.微量营养素、植物化学物质和地中海饮食:通过调节 PAF 作用和代谢对 COVID-19 的潜在保护作用。
Nutrients. 2021 Jan 30;13(2):462. doi: 10.3390/nu13020462.
2
Exploring the binding interactions of structurally diverse dichalcogenoimidodiphosphinate ligands with α-amylase: Spectroscopic approach coupled with molecular docking.探索结构多样的二硫属元素亚氨基二膦酸酯配体与α-淀粉酶的结合相互作用:光谱方法与分子对接相结合。
Biochem Biophys Rep. 2020 Nov 14;24:100837. doi: 10.1016/j.bbrep.2020.100837. eCollection 2020 Dec.
3

本文引用的文献

1
Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects.开发三(8-喹啉醇)镓(III)作为抗癌药物的进展:批判性评价与展望。
Metallomics. 2009;1(3):193-8. doi: 10.1039/b902861g. Epub 2009 Apr 9.
2
Tetrahedral and square planar Ni[(SPR(2))(2)N](2) complexes, R = Ph & (i)Pr revisited: experimental and theoretical analysis of interconversion pathways, structural preferences, and spin delocalization.四面体和平面正方形 Ni[(SPR(2))(2)N](2) 配合物,R = Ph 和 (i)Pr 的重新研究:互变途径、结构偏好和自旋离域的实验和理论分析。
Inorg Chem. 2010 Jun 7;49(11):5079-93. doi: 10.1021/ic100163g.
3
Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function .
用于评估血小板激动剂和抗血小板化合物对血小板功能影响的血小板聚集测定法。
MethodsX. 2018 Dec 26;6:63-70. doi: 10.1016/j.mex.2018.12.012. eCollection 2019.
4
A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?血小板活化因子抑制剂综述:一类新型强效金属基抗炎药物能否诱导抗癌特性?
Bioinorg Chem Appl. 2017;2017:6947034. doi: 10.1155/2017/6947034. Epub 2017 Mar 28.
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.
生物无机化学在抗癌药物开发中的当前应用和未来潜力。
Drug Discov Today. 2009 Dec;14(23-24):1089-97. doi: 10.1016/j.drudis.2009.09.003. Epub 2009 Sep 24.
4
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.蛋白酶激活受体1与血小板活化因子受体之间的相互作用调节黑色素瘤细胞粘附分子(MCAM/MUC18)的表达及黑色素瘤转移。
J Biol Chem. 2009 Oct 16;284(42):28845-55. doi: 10.1074/jbc.M109.042150. Epub 2009 Aug 24.
5
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants.血小板活化因子在癌症生长和转移中的作用:PAF抑制剂和抗氧化剂的强大有益作用
Infect Disord Drug Targets. 2009 Aug;9(4):390-9. doi: 10.2174/187152609788922555.
6
Inflammation and melanoma metastasis.炎症与黑色素瘤转移
Pigment Cell Melanoma Res. 2009 Jun;22(3):257-67. doi: 10.1111/j.1755-148X.2009.00570.x. Epub 2009 Apr 8.
7
Copper complexes as anticancer agents.铜配合物作为抗癌剂。
Anticancer Agents Med Chem. 2009 Feb;9(2):185-211. doi: 10.2174/187152009787313837.
8
Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy.血小板活化因子(PAF):关于其在哮喘中的作用及PAF拮抗剂在该疾病治疗中的临床疗效的综述
Recent Pat Inflamm Allergy Drug Discov. 2008 Jan;2(1):72-6. doi: 10.2174/187221308783399306.
9
Evaluation of anti-inflammatory and antioxidant activities of copper (II) Schiff mono-base and copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole.二烯与杂环醛和2-氨基-5-甲基噻唑的铜(II)席夫单碱和铜(II)席夫碱配位化合物的抗炎和抗氧化活性评估
J Enzyme Inhib Med Chem. 2008 Dec;23(6):1011-7. doi: 10.1080/14756360701841251.
10
Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).抗氧化剂、体外、体内抗炎活性和消炎痛及其与锰(II)、钴(II)、镍(II)、铜(II)和锌(II)的金属配合物的增殖活性。
J Enzyme Inhib Med Chem. 2009 Jun;24(3):742-52. doi: 10.1080/14756360802361589.